Why We Need Proper PBPK Models to Examine Intestine and Liver Oral Drug Absorption

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|14|1|57-79

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.14, Iss.1, 2013-01, pp. : 57-79

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PBPK Modeling of Intestinal and Liver Enzymes and Transporters in Drug Absorption and Sequential Metabolism

By  

Current Drug Metabolism, Vol. 11, Iss. 9, 2010-11 ,pp. : 743-761

Bentham Science Publishers

Access to resources Recommend Favorite

Why Do We Need New Drug Classes for HIV Treatment and Prevention?

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 12, 2016-03 ,pp. : 1343-1349

Bentham Science Publishers

Access to resources Recommend Favorite

The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability

By Chan L.M.S.   Lowes S.   Hirst B.H.  

European Journal of Pharmaceutical Sciences, Vol. 21, Iss. 1, 2004-01 ,pp. : 25-51

Elsevier

Access to resources Recommend Favorite

Interaction of Drug or Food with Drug Transporters in Intestine and Liver

By  

Current Drug Metabolism, Vol. 16, Iss. 9, 2015-11 ,pp. : 753-764

Bentham Science Publishers

Access to resources Recommend Favorite

Improving Oral Absorption Via Drug-Loaded Nanocarriers: Absorption Mechanisms, Intestinal Models and Rational Fabrication

By  

Current Drug Metabolism, Vol. 14, Iss. 1, 2013-01 ,pp. : 28-56

Bentham Science Publishers

Access to resources Recommend Favorite